What is LOPJLB’s current signal on PHIO?

LOPJLB’s latest quantitative signal on Phio Pharmaceuticals Corp. (PHIO) is SELL in a BEAR regime. Signals are updated daily.

What market regime is PHIO in?

Phio Pharmaceuticals Corp. (PHIO) is currently classified in the BEAR HMM market regime on LOPJLB.

Where is Phio Pharmaceuticals Corp. based / listed?

Phio Pharmaceuticals Corp. is based in US, listed on NASDAQ.

Phio Pharmaceuticals Corp. (PHIO)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.98+1.03%Close

SELLBEAR · day 19

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $11M
Beta: 0.80
P/E (TTM): -0.74

Short % float: 0.78%
Days to cover: 1.0
SI change: -40.3%

1W: -1.01%
1M: -2.97%

vs SPY 1W: -2.17%
vs SPY 1M: -5.96%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating…

Employees: 6
Headquarters: US
Founded: 2012
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 11.6M
Float: 99.3%

phiopharma.com ↗

Key executives

Robert J. Bitterman — President, Chief Executive Officer & Chairman

Lisa Carson — CFO, Principal Accounting Officer and VP of Finance & Administration

Jennifer Phillips — Senior Vice President of Regulatory & Corporate Affairs

SEC filings

EDGAR · CIK 15330400 · PHIO

Analyst consensus

Buy

Bullish2100.0%

Neutral00.0%

Bearish00.0%

Last$0.98

Key stats

Prediction markets

Company news